Compare HTOO & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | HTOO | ICCM |
|---|---|---|
| Founded | 2020 | 2006 |
| Country | Ireland | Israel |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | |
| Sector | Utilities | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 8.3M |
| IPO Year | 2020 | 2013 |
| Metric | HTOO | ICCM |
|---|---|---|
| Price | $2.15 | $1.95 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 29.5K | ★ 103.4K |
| Earning Date | 02-28-2023 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4,832.46 | $139.51 |
| Revenue Next Year | $81.82 | $75.66 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.80 | $0.13 |
| 52 Week High | $5.74 | $9.54 |
| Indicator | HTOO | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 39.58 | 30.72 |
| Support Level | $1.80 | $0.22 |
| Resistance Level | $2.75 | $2.50 |
| Average True Range (ATR) | 0.20 | 0.14 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 4.42 | 5.56 |
Fusion Fuel Green PLC is a provider of full-service energy engineering and advisory solutions, specializing in green hydrogen and industrial gas applications. It offers a broad portfolio of services, including the design, supply, installation and maintenance of energy systems, as well as the transport and distribution of liquefied petroleum gas. The company serves a diverse customer base spanning commercial buildings, mixed-use developments, heavy industries, and food service sectors. The group currently derives revenue by providing comprehensive solutions for the liquefied petroleum gas (LPG) industry, which includes the supply, installation, and maintenance of LPG systems, as well as transportation and delivery of LPG in both bulk and cylinder formats. It earns majority revenue from UAE.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.